ライフサイエンスコーパス: infusion

1 ignificantly lower mortality than short-term infusion.

2 owing a 7-day noradrenaline (norepinephrine) infusion.

3 hese effects were reversed by corticosterone infusion.

4 ood glucose 146 +/- 2 mg/dL) with portal GLC infusion.

5 ot affected by cold exposure or phentolamine infusion.

6 to 29 months, and 8 progressed after T-cell infusion.

7 ted in bones treated with a CXCR4 antagonist infusion.

8 ernight SAL infusion followed by SAL/OCT/INS infusion.

9 g the effectiveness of prolonged beta-lactam infusion.

10 and predominantly occurred during the first infusion.

11 nous glucose production (EGP) during insulin infusion.

12 th the use of a [1-(13)C]leucine intravenous infusion.

13 cell responses from baseline to day 28 after infusion.

14 undergoing islet transplants within hours of infusion.

15 EAs after the 20-25 min intravenous insulin infusion.

16 lex mismatched BMT with or without Treg cell infusion.

17 ticipation of monetary reward and an alcohol infusion.

18 rall used 91% less factor than before vector infusion.

19 verse events occurred during or after vector infusion.

20 eral blood chimerism was assessed after each infusion.

21 occurred a median of 6 days after CAR-T-cell infusion.

22 ad and mercury in the dry product and in the infusion.

23 d in 28-day cycles by continuous intravenous infusion.

24 erfusion, or who are receiving a vasopressor infusion.

25 vasopressin (0.03 U/min.) or norepinephrine infusions.

26 m order with a 28-day washout period between infusions.

27 kines were seen after the first BV plus Nivo infusions.

28 ulation, with the use of sedative and opioid infusions.

29 7%) of 30 patients remained on once per week infusions.

30 Dexmedetomidine infusion (0.5 microg/kg/h) during surgery and up to 2 ho

31 1)) followed by a continuous ghrelin/placebo infusion (16.9 ng/kg/min) was administered.

32 hloremia during treatment with continuous IV infusion 3% hypertonic saline, with moderate hyperchlore

33 utput syndrome with need for a catecholamine infusion 48 hours after study drug initiation, need for

34 in healthy lean males: A) 10-h overnight GCG infusion (6 ng/[kg x min]) followed by 3-h infusion of G

35 vascular dysfunction treated with vasoactive infusions a median of 5 days after T cell therapy.

36 hindered GVT effects by the combined T-cell infusion, a single injection of picogram amounts of NGR-

37 After nicotine infusion, abstinent smokers with the withdrawal risk all

38 e showed that a 30-min intraduodenal glucose infusion activated half of all duodenal L cells in human

39 s with septic shock who received vasopressin infusion added to at least one concomitant vasopressor a

40 (N=19, 26.8%)) received mood ratings before infusion, after infusion, and for the subsequent 14 days

41 by 1.27-8.82-times compared with accelerated infusion alteplase plus parenteral anticoagulants (RR 1.

42 % CI, 4.1-27.2 months) from the first T-cell infusion and 24.5 months (95% CI, 17.2-34.6 months) from

43 of safety and usability by combining insulin infusion and continuous glucose measurement in a single-

44 s into the polyphenol content of jujube leaf infusion and their antioxidant activities, a 2,2-dipheny

45 d in the lungs immediately after intravenous infusion and their survival time in the host is inconsis

46 mprove depressive symptoms within 24 h after infusion and this antidepressant effect was attributed t

47 either subcutaneously or by intravenous (IV) infusion and to assess the pharmacokinetics and in vitro

48 ated the intraportal versus systemic insulin infusion and transendothelial transport of insulin, we p

49 ncentrations of elamipretide occurred at end-infusion and were undetectable by 24 hours postinfusion.

50 proteins to an expanded LD pool during lipid infusion and, via this adaptation, may support the stora

51 gical insight, e.g. the need for intravenous infusions and restriction to short-term studies (hours)

52 OP (-/-) rats were tested for heroin (20 mug/infusion) and ethanol (10% v/v) self-administration, the

53 inemic euglycemia (bolus insulin and glucose infusion), and 3) saline control with skeletal muscle bi

54 received mood ratings before infusion, after infusion, and for the subsequent 14 days.

55 appeared more effective than intra-arterial infusion, and mobilized peripheral blood mononuclear cel

56 ein (hsCRP), FMDBA after acute ascorbic acid infusion, and vascular endothelial cell protein expressi

57 y, the total contents, leachability into tea infusions, and bioaccessibility of lithium from black, E

58 7% respondents administer sedative/analgesic infusions, and the sedation target was "sedated" or "ver

59 aline (SAL) infusion followed by GCG/OCT/INS infusion; and C) overnight SAL infusion followed by SAL/

60 infected persons, single low-dose BMS-936559 infusions appeared to enhance HIV-1-specific immunity in

61 ions, which typically occur during the first infusion, are the most frequent adverse events.

62 rther promote the consumption of jujube leaf infusion as a healthy antioxidant bedtime beverage, and

63 Ni was found to be present in the cocoa infusions as Ni(2+) and Ni-gluconate and Ni-citrate comp

64 everity was the only factor after CAR-T-cell infusion associated with infection in a multivariable an

65 ommon isatuximab-related adverse events were infusion-associated reactions (IARs) (56%), which were g

66 ent of cells for 24h with lyophilized coffee infusions at the highest dose without cytotoxic effects

67 We show that lipid infusion augments IMTG content in type I fibres of both

68 agonist) during ATP or control vasodilatator infusion, before and after KIR channel inhibition alone

69 inhibitory mold agar (IMA), and brain heart infusion (BHI) agar with chloramphenicol and gentamicin.

70 ng (CGM) and continuous subcutaneous insulin infusion can be used to improve the treatment of patient

71 To evaluate whether macronutrient infusion can suppress plasma glucagon during critical il

72 epigenetic changes induced by continuous GH infusion (cGH) in male mice, which rapidly feminizes the

73 Treg depletion during iNKT infusions completely abolished iNKT efficacy in treating

74 At the clinical infusion concentration of 5 mg.mL(-1) all glycopeptide i

75 Owing to the overall increase in herbal infusions' consumption, there's a progressively higher n

76 tions (MDI), continuous subcutaneous insulin infusion (CSII) and islet transplantation to reduce hypo

77 ump therapy (continuous subcutaneous insulin infusion; CSII) in patients with type 1 diabetes using c

78 82; 95% CI, 0.68-0.98), and fewer vasoactive infusion days (3.0 vs 3.3 d; p < 0.001) when compared wi

79 dinner.Thirteen participants completed the 4 infusion days.

80 matory cardiovascular dysfunction, apelin-13 infusion delivers distinct and optimized hemodynamic sup

81 intravenous infusion, whereas intracoronary infusion demonstrated no improvement.

82 Intracoronary saline infusion did not affect blood pressure, systolic, or dia

83 nges in cardiac troponin T levels during the infusion did not differ between the two groups in the 55

84 G-CSF with or without haemopoietic stem-cell infusion did not improve liver dysfunction or fibrosis a

85 rong burst of thrombin and plasmin, FXa/PCPS infusion did not produce measurable levels of complement

86 To determine whether fibrinogen concentrate infusion dosed to achieve a plasma fibrinogen level of 2

87 Avelumab was given as a 1-h intravenous infusion every 2 weeks.

88 or 1000 mg meropenem (by 30-min intravenous infusion every 8 h) for 7-14 days; regimens were adjuste

89 ime and 500 mg avibactam (by 2 h intravenous infusion every 8 h) or 1000 mg meropenem (by 30-min intr

90 received avelumab (10 mg/kg, 1 h intravenous infusion) every 2 weeks until confirmed disease progress

91 he activity enhancement in the two-component infusion evidently results from a cooperative effect in

92 ments, including imaging experiments, direct infusion experiments, and experiments employing liquid c

93 basal replacement; B) overnight saline (SAL) infusion followed by GCG/OCT/INS infusion; and C) overni

94 y GCG/OCT/INS infusion; and C) overnight SAL infusion followed by SAL/OCT/INS infusion.

95 C/EC) coculture system as well as in vivo EC infusions following myelosuppressive injury in mice to d

96 atment period, subjects underwent a ketamine infusion for 75 min during which the effects of PF-04958

97 Current treatment is based on plasma infusion for congenital TTP, or plasma exchange, often i

98 treatment with serelaxin intravenous (i.v.) infusion (for 60 min at 80 mug/kg/d and then 60 min at 3

99 o enhance the standard of care by decreasing infusion frequency to increase compliance, promoting pro

100 Rose petals and calendula infusions gave the highest content of organic acids, mai

101 ere more frequent the in G-CSF and stem-cell infusion group (12 [43%] patients) than in the G-CSF (th

102 care and p=0.75 for the G-CSF plus stem-cell infusion group vs standard care).

103 SF group, and 28 to the G-CSF plus stem-cell infusion group.

104 Conversely, dHc TLQP-62 infusion had rapid antidepressant efficacy, which was re

105 ials used as ingredients of herbal and fruit infusions (HFI) were analysed by means of ICP-MS for the

106 cy/resolution mass spectrometry after direct infusion (i.e., shotgun lipidomics).

107 sal hippocampal, ventral hippocampal, or ACC infusions immediately 'before' testing (retrieval) did n

108 cells by pancreatic intra-ductal AAV8-shAtg7 infusion in C57BL/6 mice, resulted in decreased beta cel

109 on in mPFC, whereas LMA was increased (after infusion in IL only).

110 sis is significantly blunted following IGF-1 infusion in knockout (RIT1 (-/-) ) mice.

111 during US presentations or in the ITI) after infusion in mPFC, whereas LMA was increased (after infus

112 autologous CD34+ cell (CLBS10) intracoronary infusion in patients with left ventricular dysfunction p

113 lic volume (-14 mL; P=0.005) occurred at end infusion in the highest dose cohort.

114 dex, received either a 6 h lipid or glycerol infusion in the setting of a concurrent hyperinsulinaemi

115 In both groups, lipid infusion increased IMTG content in type I fibres (traine

116 In trained individuals, lipid infusion increased the number of LDs associated with PLI

117 Post-infusion/injection serum VRC01 retained expected functio

118 Moreover, angiotensin II infusion instigated interferon-gamma, which induced the

119 , either after autologous transplantation or infusion into immunodeficient mice.

120 responses is provided by evidence that HMGB1 infusion into the hippocampus was sufficient to cause an

121 al(+/-) mice were replicated by oxotremorine infusion into the striatum, but not into the cerebellum,

122 AE) was identified 266 days after BMS-936559 infusion; it resolved over time.

123 as well as weekly maternal IV immunoglobulin infusion (IVIG), with or without additional corticostero

124 h different timing, both FXa/PCPS and E coli infusion led to robust thrombin and plasmin generation.

125 Furthermore, amino acid infusion likely results in a further breakdown of amino

126 An Angiotensin II (AngII)-aldosterone (Ald) infusion mouse model of hypertension was utilised in thi

127 secutive cohorts, 0.3-100 mg/kg) or 4 weekly infusions (n = 16; 2 consecutive cohorts, 30 and 60 mg/k

128 d showed that in the presence of the alcohol infusion, nalmefene significantly reduced the BOLD respo

129 entional dosing of 16 g/2 g/24 hr continuous infusion, obese patients were more likely than nonobese

130 lmonary embolism was induced by jugular vein infusion of (125)I-fibrin or fluorescein isothiocyanate-

131 hanced nitrogen flux into the urea cycle and infusion of (15)N-arginine shows that Arg2 loss causes s

132 In vivo infusion of (15)N-glutamine in obese mouse models of PDA

133 IV infusion of 1, 2, 3, or 4 mL/Kg (body weight) of crystal

134 Subarachnoid infusion of 1-2 ml of fresh blood at 200 microl/min over

135 racranial multiphoton imaging, we found that infusion of 100 ng of HIV-1 Tat into the lateral ventric

136 Patients received an intravenous infusion of 7.5 mg/kg MABp1 or placebo given every 2 wee

137 In addition, intra-mPFC infusion of a BDNF-neutralizing antibody was performed t

138 Infusion of a simianized anti-alpha4beta7 mAb (Rh-alpha4

139 ier and the value calculated from the simple infusion of a solution of polymer into the commercial at

140 Infusion of a T-cell-depleting anti-CD8beta monoclonal a

141 The infusion of AAV5-hFVIII-SQ was associated with the susta

142 An infusion of acetaminophen 1 g or saline placebo over 15

143 targets in these neurons and show that local infusion of agonists for specific receptors on these neu

144 cal treatment were randomized to intravenous infusion of allogenic UC-MSCs (Cellistem, Cells for Cell

145 d therapy, streptokinase and non-accelerated infusion of alteplase were significantly associated with

146 Compared with accelerated infusion of alteplase with parenteral anticoagulants as

147 In critically ill mice, infusion of amino acids increased glucagon and up-regula

148 Both acute administration and chronic infusion of an RGD synthetic peptide to obese C57BL/6 mi

149 We then tested the effect of 4-week infusion of AngII (400 ng/kg per minute) in APA-KO and w

150 purate), BP, and hemodynamic responses to an infusion of angiotensin II (assessment of intrarenal ren

151 INTERPRETATION: Prolonged infusion of antipseudomonal beta-lactams for the treatme

152 ous or >/=3 h) versus short-term (</=60 min) infusion of antipseudomonal beta-lactams for the treatme

153 effectiveness of prolonged versus short-term infusion of antipseudomonal beta-lactams in patients wit

154 Infusion of AOPCP in vivo significantly decreased the hy

155 The intravenous infusion of apolipoprotein E4 exacerbated the brain accu

156 Acute infusion of ascorbic acid to inhibit superoxide producti

157 However, the responses after intracoronary infusion of autologous bone marrow-derived mononuclear c

158 be also delivered intratumorally, including infusion of autologous dendritic cells and even tumor-re

159 for 5 days, followed by a single intravenous infusion of autologous TILs and high-dose interleukin-2

160 As previously reported, infusion of BDNF into the PrL cortex blocked cocaine SA-

161 trieval of non-social and social memory, icv infusion of BIBO3304 trifluoroacetate and BIIE0246 block

162 dministration of caspase-1 inhibitors or the infusion of bone marrow-derived macrophages genetically

163 In women with severe post-partum depression, infusion of brexanolone resulted in a significant and cl

164 The early transient (3 days) post-SE infusion of bumetanide reduced rMF sprouting and recurre

165 Lymphodepletion chemotherapy followed by infusion of CD19-specific chimeric antigen receptor-modi

166 After infusion of Cy, a marked reduction of proliferating NK c

167 oproteins was studied using a stable isotope infusion of D3-leucine, gas chromatography/mass spectrom

168 To evaluate whether an intraoperative infusion of dexmedetomidine reduces postoperative deliri

169 Collectively, these findings suggest that infusion of donor ILC2s to restore gastrointestinal trac

170 failure to receive a continuous intravenous infusion of either ularitide at a dose of 15 ng per kilo

171 tion fraction and demonstrates that a single infusion of elamipretide is safe and well tolerated.

172 ize the vascular effects of a mixed meal and infusion of exogenous glucose-dependent insulinotropic p

173 Infusion of fluorescent beads 3 d before pFUS+MB reveale

174 In vivo focal infusion of GABA or GABA reuptake inhibitor to sensory g

175 G infusion (6 ng/[kg x min]) followed by 3-h infusion of GCG, octreotide (OCT), and insulin (INS) for

176 ats was also attenuated (n = 7; P < 0.01) by infusion of gp91ds-tat, a peptide that blocks the activi

177 ngth IgG could be enhanced by intrathecal co-infusion of hyperosmolar mannitol.

178 sympathoexcitatory and pressor response than infusion of hypertonic mannitol/sorbitol.

179 ABSTRACT: Systemic or central infusion of hypertonic NaCl and other osmolytes readily

180 ugh a central osmoreceptor; however, central infusion of hypertonic NaCl produces a greater sympathoe

181 at baseline then 24 h following intravenous infusion of ketamine (0.5 mg/kg).

182 MDD patients received a single infusion of ketamine and underwent repeated rs-fcMRI at

183 Patients were assigned to a 24-hour infusion of levosimendan 0.1 microg/kg/min (n = 167) or

184 intervention group (n=14) received a single infusion of MSC (1.0 x 10(5) or 2.5 x 10(5) cells/kg; n=

185 While icv infusion of NPY did not affect the acquisition, consolid

186 hemoablation with ethanol lavage followed by infusion of paclitaxel is effective for the treatment of

187 vascular conductance (FVC) to intra-arterial infusion of phenylephrine (PE; alpha1 -agonist) during A

188 In normal rats, the infusion of rat recombinant FGF23 enhanced phosphaturia

189 Intracoronary infusion of saline at room temperature through a dedicat

190 d at 5-15-minute intervals for 4 hours after infusion of study drug.

191 male volunteers without and with concurrent infusion of the ABCB1 inhibitor tariquidar.

192 Infusion of the CP-AMPAR-specific blocker Naspm into the

193 infusion of the ETA antagonist did not completely block

194 platelet IgG Fc receptor IIA (FcgammaRIIA), infusion of the HIT-like monoclonal antibody KKO increas

195 Importantly, infusion of the nitric oxide synthase inhibitor l-N(G)-m

196 Equimolar infusion of the VPAC1/2 receptor ligand vasoactive intes

197 Infusion of tiron, a superoxide scavenger, attenuated th

198 sed ultrasound (pFUS) combined with systemic infusion of ultrasound contrast agent microbubbles (MB)

199 oppler) were measured before and after rapid infusion of warmed saline (15 mL kg(-1) , approximately

200 Intravenous infusions of (13)C-labelled nutrients reveal that, on a

201 ed randomized trial of rituximab (2 biweekly infusions of 1g each).

202 according to the lymphoma protocol (4 weekly infusions of 375 mg/m2).

203 individuals with schizophrenia to 3 monthly infusions of 8 mg/kg tocilizumab or placebo (normal sali

204 n mice that received intracerebroventricular infusions of AbetaOs.

205 ually to receive 15 double-blind intravenous infusions of adjunctive lanicemine 50 mg, lanicemine 100

206 edly higher locomotor responses to intra-VTA infusions of AMPA, suggesting a paradoxical increase in

207 Disrupting synapses and motor maps by infusions of anisomycin (ANI) into anatomically reorgani

208 Following infusions of B/M or vehicle in the PL, responding was te

209 Post-training infusions of CGP into the ACC, however, did not promote

210 Mice received monthly subcutaneous infusions of cytokines while also being assessed at mont

211 ways was achieved using unilateral intra-PFC infusions of DA antagonists combined with contralateral

212 In the present work, the edible petals and infusions of dahlia, rose, calendula and centaurea, were

213 Infusions of eighty commercial teas (sold in bags or lea

214 arm blood flow in response to intra-arterial infusions of endothelial-dependent and -independent vaso

215 Our data show that prefrontal infusions of KYNA attenuated the inhibitory component of

216 al (i.p.) doses of ketamine or memantine, or infusions of memantine directly into the prelimbic (PLmP

217 However, infusions of normal adult rat renal cells have been a su

218 Infusions of plasma-derived C1 esterase inhibitor deter

219 We used bilateral intracranial infusions of propranolol into either the infralimbic div

220 showed the antifibrotic effects of repeated infusions of purified HSCs.

221 Bolus infusions of saline and isoproterenol (1 or 2 mug) were

222 Colonic infusions of SCFA mixtures, in concentrations and ratios

223 Intra-VTA infusions of selective CRF1R and/or CRF2R compounds were

224 Repeated infusions of TCZ were well tolerated.

225 , and biomechanics under acute or continuous infusions of the apelinergic agonists ELA or Apelin-13 (

226 ; 2 consecutive cohorts, 30 and 60 mg/kg per infusion) of TNT009 or placebo.

227 ur cycles of 175 mg/m(2) paclitaxel as a 3 h infusion on day 1 every 3 weeks) or epirubicin, cyclopho

228 ycles, administered intravenously as a 0.5 h infusion on days 1 and 8 every 3 weeks).

229 Conversely, we found no effect of tiron infusion on the pressor reflex in rats with patent femor

230 f these pregnancies with prophylactic plasma infusions (one pregnancy resulted in p-aHUS, one intraut

231 Stearic acid infusion only increased C17:0.

232 ents of composite processing including resin infusion, onset of crosslinking, gel time, degree and ra

233 , we discovered that intracerebroventricular infusion or local OVLT injection of hypertonic NaCl incr

234 pressure overload by means of angiotensin-II infusion or transversal aortic constriction.

235 Removal of NETs via DNase infusion, or in peptidylarginine deiminase-4-deficient m

236 L-leucovorin 175 mg or D,L-leucovorin 350 mg infusion over 2 h, and 400 mg/m(2) bolus fluorouracil fo

237 Gramont chemotherapy; 85 mg/m(2) oxaliplatin infusion over 2 h, L-leucovorin 175 mg or D,L-leucovorin

238 ed by a 2400 mg/m(2) continuous fluorouracil infusion over 46 h).

239 nezumab (15 mg/kg) or placebo as intravenous infusions over 1 h every 2 weeks for 46 weeks, followed

240 Heart rate decreased by 15% during saline infusion (P=0.021).

241 Four weeks after AngII-Ald infusion, PAI-1-deficient (PAI-1(-/-)) mice developed se

242 tive lever press resulted in an i.v. cocaine infusion paired with one of two cues that alternated wit

243 eir harvesting pre-transplant, expansion and infusion post-transplantation.

244 iotracer was administered using a bolus-plus-infusion protocol, the arterial input function was measu

245 ans using rubidium-82 with various adenosine infusion protocols identified (1) the protocol with maxi

246 ppearance (glucose RA) during three separate infusion protocols in healthy lean males: A) 10-h overni

247 igate whether perioperative hepatic arterial infusion pump chemotherapy (HAI) was associated with ove

248 Glucose infusion rates (GIRs) had to be increased more after nas

249 Grade 1-2 infusion reactions occurred in 15 patients, but no grade

250 In experiment 3, intra-BNST PACAP infusion reinstated previously extinguished cocaine-seek

251 al by immune cells and may contribute toward infusion-related adverse effects such as allergic respon

252 of any grade were fatigue/asthenia (31.8%), infusion-related reaction (20.5%), and nausea (11.4%).

253 ade were fatigue (46 [25%] of 184 patients), infusion-related reaction (38 [21%]), and nausea (23 [13

254 n (occurring in more than two patients) were infusion-related reaction (four [2%] patients) and incre

255 Infusion-related reactions, which typically occur during

256 effect of NPS seen after i.c.v. or intra-PVN infusion requires responsive OXT neurons of the PVN and

257 Chronic sphingosine-1-phosphate (S1P) infusion resulted in a development of significantly incr

258 b(-/-)) mice and intravenous myeloperoxidase infusion revealed that neutrophil infiltration is a prer

259 lacebo-controlled trial of a single ketamine infusion (saline, 0.2 mg/kg, 0.5 mg/kg).

260 ignificantly increased the number of alcohol infusions self-administered (percent change: 24.97+/-10.

261 356, 494) were achieved 1 hour after the IV infusion series of 30 mg/kg and 10 mg/kg doses, respecti

262 nce based CGM system into a standard insulin infusion set.

263 Osmolyte co-infusion significantly enhanced perivascular access of t

264 1) and in two patients in the placebo group (infusion site pain, n=1; tension headache, n=1); one pat

265 blood stream in the tumour region around the infusion site.

266 In vivo IL-6 infusion stimulates a robust increase in lysosomes in th

267 who participated in an intravenous nicotine infusion study that followed overnight smoking abstinenc

268 enous alcohol using the Computerized Alcohol Infusion System.

269 nfirmed or excluded by an intravenous saline infusion test or captopril challenge test and subtype di

270 showed a higher urinary pH at the end of the infusion than patients randomized to the saline group (n

271 At the end of infusion, the estimated (89)Zr-trastuzumab in plasma vol

272 lative to baseline at greater than 24 h post-infusion, the most robust reduction observed to date in

273 ltrasound (cerebral blood flow) and constant infusion thermodilution (femoral blood flow) with net ex

274 After 48 hours of brexanolone infusion, TLAs were weaned during brexanolone maintenanc

275 travenous alcohol administration (6% vol/vol infusion to achieve a target level of 80 mg/dL).

276 ancreatic clamping with a [U-(13)C]palmitate infusion to determine the insulin concentration needed t

277 , 90 degrees C) and the standing time of the infusion (up to 6h).

278 mposite end point of prolonged catecholamine infusion, use of left ventricular mechanical assist devi

279 Total FWB infusion volume was similar for REBOA (2,452 +/- 0 mL) a

280 Vasopressor infusion (VPI) is used to treat hypotension in an ICU.

281 rate by IWCLL imaging criteria 4 weeks after infusion was 74% (CR, 4/19, 21%; PR, 10/19, 53%), and 15

282 ILC2 infusion was associated with reduced donor proinflammato

283 in the pgACC caused by ketamine at 24 h post infusion was reproduced in an enlarged sample (placebo,

284 Propofol infusion was titrated to maintain stable vital signs and

285 itabine 1000 mg/m(2) as a 30-min intravenous infusion, weekly, for 7 weeks followed by a 1-week break

286 Ketamine and placebo infusions were administered in a random order with a 28-

287 were prepared by microwave digestion, while infusions were analyzed without any pre-treatment.

288 Th, and U) in green coffee samples and their infusions were determined by using inductively coupled p

289 f catechins and other phenolics in green tea infusions were monitored using fast HPLC/MS separation.

290 eparation, the antioxidant properties of the infusions were monitored using two spectrophotometric me

291 Infusions were well tolerated, with no dose-limiting tox

292 MSC infusions were well tolerated.

293 y injury, and shorter duration of vasoactive infusions when compared with exclusive use of unbalanced

294 ct intramyocardial injection and intravenous infusion, whereas intracoronary infusion demonstrated no

295 al bone-marrow recovery within 5 days of HSC infusion, which was up to 20 days before engraftment bec

296 ase in LV end-diastolic pressure with saline infusion, while enhancing the saline-mediated increase i

297 tients (23%) within 28 days after CAR-T-cell infusion with an infection density of 1.19 infections fo

298 The 6-minute adenosine infusion with rubidium-82 activation at 3 minutes produc

299 tly 15.7% higher than the 4-minute adenosine infusion with rubidium-82 injection at 2 minutes and sig

300 The adenosine 6-minute infusion with rubidium-82 injection at 3 minutes caused